Cainazzo, Maria Michela
Baraldi, Carlo https://orcid.org/0000-0001-8432-1888
Ferrari, Anna
Lo Castro, Flavia
Pani, Luca
Guerzoni, Simona
Article History
Received: 30 October 2020
Accepted: 30 January 2021
First Online: 5 February 2021
Declarations
:
: The study was approved by the Area Vasta Emilia Nord Ethics Committee (protocol number: 50/2020/OSS/AOUMO). All procedures were conducted in accordance with the latest version of the Declaration of Helsinki.
: Every subject signed an informed consent to participate the study.
: Every subject signed an informed consent for the publication of the results of the study.
: MMC, FLC, and AF do not have conflicts of interest to declare. CB received travel grants from Allergan and Ely Lilly. SG received travel grants and honoraria from Allergan and Eli Lilly. LP is the Chief Scientific Officer of EDRA-LSWR Publishing Company and of Inpeco SA Total Lab Automation Company. In the last year, he has been a scientific consultant to AbbVie, USA; BCG, Switzerland; Boehringer-Ingelheim, Germany; Compass Pathways, UK; Johnson & Johnson, USA; Takeda, USA; VeraSci, USA; Vifor, Switzerland.